K. Dorsch-Vogel

A pilot study of molecularly tailored therapy for patients with metastatic pancreatic cancer (MPC).

J. Marshall, L. Weiner, Hongkun Wang, 2015 .

A phase 1 trial of GMX1777: An inhibitor of nicotinamide phosphoribosyl transferase (NAMPRT)

M. Berger, J. Marshall, M. Pishvaian, 2008 .

A phase 2 study of the PARP inhibitor veliparib plus temozolomide in patients with heavily pretreated metastatic colorectal cancer

J. Marshall, L. Weiner, M. Pishvaian, 2018, Cancer.

Phase II study of temozolomide and veliparib combination therapy for sorafenib-refractory advanced hepatocellular carcinoma

J. Marshall, Hongkun Wang, M. Pishvaian, 2015, Cancer Chemotherapy and Pharmacology.

Phase II trial of temozolomide and veliparib combination therapy for sorafenib-refractory advanced hepatocellular carcinoma (HCC).

J. Marshall, L. Weiner, Hongkun Wang, 2014 .

A phase II study of the PARP inhibitor ABT-888 plus temozolomide in patients with heavily pretreated, metastatic colorectal cancer.

J. Marshall, L. Weiner, M. Pishvaian, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.